Skip to content

Clinical validation of new markers for chronic heart failure

Clinical validation of new markers for chronic heart failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018574
Enrollment
Unknown
Registered
2018-09-25
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure

Interventions

Gold Standard:Clinical outcome
Index test:miR155

Sponsors

The First Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria of chronic heart failure; (2) NYHA cardiac function classification is grade II; (3) Aged 20 to 80 years; (4) agree to participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) heart failure due to liver and kidney failure; (2) pregnant or lactating women, allergic constitution and allergic to multiple drugs; (3) combined with severe primary diseases such as liver, kidney and endocrine system, hematopoietic system, etc.; (4) mentally abnormal and unwilling to cooperate; (5) the patients took part in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
miR155;

Countries

China

Contacts

Public ContactXinyu Chen

The First Hospital of Hunan University of Chinese Medicine

chenxinyuchen@163.com+86 13807312410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026